Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James B Rowe

Showing results (271-280 of 459) with videos related to

Pageof 46
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|July 12, 2020
Synaptic Loss in Primary Tauopathies Revealed by [<sup>11</sup> C]UCB-J Positron Emission TomographyNegin Holland, P Simon Jones, George Savulich, et al.
Brain Communications|March 20, 2023
Uncovering spatiotemporal patterns of atrophy in progressive supranuclear palsy using unsupervised machine learningWilliam J Scotton, Cameron Shand, Emily Todd, et al.
Neurobiology of Aging|February 25, 2021
Imaging tau burden in dementia with Lewy bodies using [<sup>18</sup>F]-AV1451 positron emission tomographyElijah Mak, Nicolas Nicastro, Maura Malpetti, et al.
Journal of Neurology|April 27, 2018
Longitudinal diffusion tensor imaging changes in early Parkinson's disease: ICICLE-PD studyThais Minett, Li Su, Elijah Mak, et al.
Neurobiology of Aging|March 5, 2019
Functional network resilience to pathology in presymptomatic genetic frontotemporal dementiaTimothy Rittman, Robin Borchert, Simon Jones, et al.
Plos Computational Biology|May 9, 2022
Noradrenergic deficits contribute to apathy in Parkinson's disease through the precision of expected outcomesFrank H Hezemans, Noham Wolpe, Claire O'Callaghan, et al.
Brain : a Journal of Neurology|March 30, 2021
Locus coeruleus integrity and the effect of atomoxetine on response inhibition in Parkinson's diseaseClaire O'Callaghan, Frank H Hezemans, Rong Ye, et al.
Human Brain Mapping|January 13, 2016
Predicting beneficial effects of atomoxetine and citalopram on response inhibition in Parkinson's disease with clinical and neuroimaging measuresZheng Ye, Charlotte L Rae, Cristina Nombela, et al.
International Journal of Geriatric Psychiatry|May 27, 2021
Dementia wellbeing and COVID-19: Review and expert consensus on current research and knowledge gapsKathy Y Liu, Robert Howard, Sube Banerjee, et al.
Human Brain Mapping|May 21, 2025
Neurophysiological Progression in Alzheimer's Disease: Insights From Dynamic Causal Modelling of Longitudinal MagnetoencephalographyAmirhossein Jafarian, Melek Karadag Assem, Ece Kocagoncu, et al.
Pageof 46

Showing results (271-280 of 459) with videos related to

Sort By:
Pageof 46
Movement Disorders : Official Journal of the Movement Disorder Society|July 12, 2020
Synaptic Loss in Primary Tauopathies Revealed by [<sup>11</sup> C]UCB-J Positron Emission TomographyNegin Holland, P Simon Jones, George Savulich, et al.
Brain Communications|March 20, 2023
Uncovering spatiotemporal patterns of atrophy in progressive supranuclear palsy using unsupervised machine learningWilliam J Scotton, Cameron Shand, Emily Todd, et al.
Neurobiology of Aging|February 25, 2021
Imaging tau burden in dementia with Lewy bodies using [<sup>18</sup>F]-AV1451 positron emission tomographyElijah Mak, Nicolas Nicastro, Maura Malpetti, et al.
Journal of Neurology|April 27, 2018
Longitudinal diffusion tensor imaging changes in early Parkinson's disease: ICICLE-PD studyThais Minett, Li Su, Elijah Mak, et al.
Neurobiology of Aging|March 5, 2019
Functional network resilience to pathology in presymptomatic genetic frontotemporal dementiaTimothy Rittman, Robin Borchert, Simon Jones, et al.
Plos Computational Biology|May 9, 2022
Noradrenergic deficits contribute to apathy in Parkinson's disease through the precision of expected outcomesFrank H Hezemans, Noham Wolpe, Claire O'Callaghan, et al.
Brain : a Journal of Neurology|March 30, 2021
Locus coeruleus integrity and the effect of atomoxetine on response inhibition in Parkinson's diseaseClaire O'Callaghan, Frank H Hezemans, Rong Ye, et al.
Human Brain Mapping|January 13, 2016
Predicting beneficial effects of atomoxetine and citalopram on response inhibition in Parkinson's disease with clinical and neuroimaging measuresZheng Ye, Charlotte L Rae, Cristina Nombela, et al.
International Journal of Geriatric Psychiatry|May 27, 2021
Dementia wellbeing and COVID-19: Review and expert consensus on current research and knowledge gapsKathy Y Liu, Robert Howard, Sube Banerjee, et al.
Human Brain Mapping|May 21, 2025
Neurophysiological Progression in Alzheimer's Disease: Insights From Dynamic Causal Modelling of Longitudinal MagnetoencephalographyAmirhossein Jafarian, Melek Karadag Assem, Ece Kocagoncu, et al.
Pageof 46